Abstract
This article aims to increase awareness about the utility of 18F -FDG-PET/CT in the evaluation of cranial nerve (CN) pathology. We discuss the clinical implication of detecting perineural tumor spread, emphasize the primary and secondary 18F -FDG-PET/CT findings of CN pathology, and illustrate the individual 18F -FDG-PET/CT CN anatomy and pathology of 11 of the 12 CNs.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Background
Conventional CT and MRI have been the imaging modalities of choice for evaluation of cranial nerve (CN) pathology. However, CN pathology can also be detected on [18 F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT) imaging [1–3]. As FDG PET/CT is increasingly being used for oncologic imaging and more specifically for evaluation of head and neck (HN) cancer [4], PET/CT interpreters need to familiarize themselves with the image findings of CN involvement, which will greatly impact the staging and management of these patients.
Tumor related PET/CT findings include the perineural spread of HN tumors which represents a rare contiguous metastatic extension of tumor along a cranial nerve that portends to poor prognosis, even if the patient is asymptomatic [2, 5]. If present, treatment can be changed to include neck dissection, a larger radiation field, or adding adjuvant therapy [6–8]. Facial nerve involvement (CN VII) in parotid tumors may preclude facial nerve–sparing surgery or require additional treatment modality [9]. Patients with skin cancer and perineural invasion will require adjuvant radiation therapy even when clear margins are achieved with Mohs surgery [10, 11]. Also the degree of FDG uptake by the tumor as measured by the SUV max is an important prognostic marker for locally advanced nasopharyngeal cancer. High FDG uptake reflects more aggressive tumors that may require more aggressive treatment and carries a worse prognosis, as compared to the less aggressive low FDG tumors [12].
Non-tumor related benign and malignant cranial nerve pathology can also be incidentally detected during PET/CT oncologic imaging including schwannomas [13], optic nerve glioma [14], meningioma [15], and melanoma [15]. Gallium 68 (68Ga) 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaceticacid (DOTA)–octreotate (DOTATATE, GaTate), has been shown to be more sensitive than FDG-PET/CT in detection of low grade somatostatin receptor positive tumors namely meningioma, esthesioneuroblastoma and schwannoma [16].
The purpose of this article is to describe the primary and secondary FDG-PET/CT findings of CN pathology and to provide a comprehensive illustration of the PET/CT cross-sectional anatomy and pathology of almost each individual CN, thus raising awareness and familiarity about incidental CN lesions seen on PET/CT, which will directly reflect on patient staging and management.
Primary and secondary PET/CT findings of CN pathology
The primary sign of CN pathology includes linear thickening or linear increased/decreased FDG activity along the expected course of the CN (Fig. 1). For this purpose, all three planes (axial, coronal and sagittal) and maximum intensity projection (MIP) images must be evaluated and correlations with all other available imaging modalities, e.g. (CT or MRI) which will often confirm the abnormality.
The secondary signs of CN pathology include widening or destruction at the corresponding skull base foramen, asymmetric atrophy or abnormal activity in the muscles supplied by the CN, or increased FDG activity related to synergistic/antagonistic muscle overcompensation to maintain function (Table 1).
Case presentation
Olfactory nerve (CN I)
Direct visualization of the CN I lesion is beyond the resolution of PET/CT, however CN I involvement should be suspected in lesions involving the superior sinonasal and anterior cranial fossa region. The differential considerations include olfactory neuroblastoma (Esthesioneuroblastoma), sinonasal carcinoma and melanoma (Fig. 2)
.
Optic nerve (CN II)
The main differential considerations for CN II lesion include optic pathway glioma (OPG), optic nerve sheath meningioma, idiopathic orbital inflammatory pseudotumor, and optic neuritis. FDG activity in Optic nerve glioma is variable depending on its histological grade [17, 18]. Some authors suggested the use of FDG-PET/CT in monitoring malignant transformation of OPG in children with neurofibromatosis type 1 syndrome [17, 19]. Optic meningioma is a benign tumor that typically demonstrate minimal to no FDG uptake on PET [15] and can be associated with bony sclerosis/destruction as in our case (Fig. 3). Orbital pseudotumor could be both hyper or isometabolic on FDG PET [18]. Xie et al. described a 56-year-old female with elevated FDG activity in several cranial and peripheral nerves suggestive of multiple neuritis, with patient“s symptoms improving following treatment [3].
Oculomotor, trochlear and abducens nerves (CN III, IV, VI)
Direct visualization of CNs III, IV and VI is usually beyond the resolution of PET/CT, however large brain stem or cavernous sinus lesions along the course of these nerves may indicate cranial nerve involvement by these lesions. Also, extraocular muscle atrophy or asymmetric decreased uptake could represent denervation injury, which should prompt a search for a lesion along the course of the innervating CN. In an attempt to compensate for the paralyzed muscle, the non affected extraocular muscles may show increased FDG activity, further confirming the CN involvement (Fig. 4c–e).
Trigeminal nerve, maxillary and mandibular divisions (CNV, V2 & V3)
FDG-PET/CT can detect perineural tumor spread along the trigeminal nerve and its main divisions; most commonly arising from head and neck squamous cell carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, skin cancer and melanoma as well as [2] lymphoma [1] and neurolymphomatosis [20] (Fig. 5)
.
Facial/ vestibulocochlear nerve complex (CNVII and VIII)
The most common cerebellopontine angle lesions are vestibular schwannoma and meningioma. Vestibular schwannoma is typically described as a hypometabolic lesion [21], however in our experience they were hypermetabolic (Fig. 6c-f), which may be related to the large size of the lesions. Vestibular schwannoma is differentiated from meningioma by extension into the internal auditory canal (Fig. 6f). The less common facial nerve schwannoma is diagnosed when the lesion extends along the labyrinthine segment of CNVII (Fig. 6g, h). Perineural spread form parotid gland lesions should be suspected with abnormal activity extending superiorly along the stylomastoid foramen or within the temporal bone [2, 22, 23]. Rare CN melanoma metastasis along CNs VII and VIII has also been described [24].
Vagus and spinal accessory nerves (CNs X and XI)
The most common jugular foramen (JF) lesions that my involve CN X and XI are glomus juglare, schwannoma, meningioma and skull base metastasis. Looking at the bone margins of the JF on the bone window of PET/CT may help differentiate glomus tumors which tend to have a permeative destructive margins from schwannoma which tend to cause smooth expansion of the JF (Fig. 7e) and meningioma, which may have permeative sclerotic margins [25]. If the recurrent laryngeal branch of CNX is involved, it will be seen as a hypometabolic ipsilateral paralyzed vocal cord with a hypermetabolic overcompensating contralateral vocal cord (Fig. 7c, d). Ipsilateral shoulder dropping on MIP images (Fig. 7g), with atrophy of the trapezius and sternomastoid muscles on the axial images (Fig. 7c, d), signifies CNXI involvement, which could be secondary to CNXI sacrifice during neck dissection.
Hypoglossal nerve (CN XII)
Injury of CNXII could occur by the aforementioned JF lesions [25]. Further distally it could be secondary to hypoglossal foramen lesions (CNXII Schwannoma [25, 26]), clival tumor (chordoma, chondrosarcoma and plasmacytoma) [25], or rarely could be secondary to retrospective perineural tumor spread from tongue base tumor or radiation injury. An atrophic sagging fatty infiltrated ipsilateral tongue will be seen with hypometabolism on PET/CT (Fig. 8 b, d, e) [25].
Conclusion
Cranial nerve pathology can be detected on FDG PET/CT. With the increased reliance on PET/CT in patient staging and follow-up, PET/CT interpreters should familiarize themselves with these findings as it may change patient staging and management.
Consent
“This retrospective study was approved by the Saint Louis University IRB board”.
Abbreviations
- FDG:
-
[18 F]-2- deoxy-D-glucose
- PET/CT:
-
Positron emission tomography with computerized tomography
- CN:
-
Cranial nerve
- HN:
-
Head and neck
- CPA:
-
Cerebellopontine angle lesion
- IAC:
-
Internal auditory canal
- JF:
-
Jugular foramen
- CN I:
-
Olfactory nerve
- CN II:
-
Optic nerve
- CN III:
-
Oculomotor nerve
- CN IV:
-
Trochlear nerve
- CN V:
-
Trigeminal nerve
- CN V1:
-
Ophthalmic division of trigeminal nerve
- CN V2:
-
Maxillary division of trigeminal nerve
- CN V3:
-
Mandibular division of trigeminal nerve
- CN VI:
-
Abducens nerve
- CN VII:
-
Facial nerve
- CN VIII:
-
Vestibulocochlear nerve
- CN IX:
-
Glossopharyngeal nerve
- CN X:
-
Vagus nerve
- CN XI:
-
Spinal accessory nerve
- CN XII:
-
Hypoglossal nerve
- FIESTA:
-
Fast imaging employing steady-state acquisition
- MPR:
-
Multiplanar reformatted images
- SSFP:
-
Steady state free precession
- STIR:
-
Short tau inversion recovery
- MIP:
-
Maximum intensity projection
References
Yılmaz S, Sağer S, Sen F, Halac M. Bilateral trigeminal nerve recurrence of non-hodgkin lymphoma revealed with FDG PET/CT. Indian J Nucl Med. 2014;29(1):50–2.
Paes FM, Singer AD, Checkver AN, Palmquist RA, De La Vega G, Sidani C. Perineural spread in head and neck malignancies:clinical significance and evaluation with 18F-FDG PET/CT. Radiographics. 2013;33(6):1717–36.
Xie X, Cheng B, Han X, Liu B. Findings of multiple neuritis on FDG PET/CT imaging. Clin Nucl Med. 2013;38(1):67–9.
Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(8):917–23.
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379–91.
Salamaa J, Sabab N, Quonc H, Gargd M, Lawsone J, McDonaldf M, et al. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol. 2011;47(7):554–9.
Tai SK, Li WY, Yang MH, Chang SY, Chu PY, Tsai TL, et al. Treatment for T1–2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy. Ann Surg Oncol. 2012;19(6):1995–2002.
Chatterjee S, Frew J, Mott J, McCallum H, Stevenson P, Maxwell R, et al. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study. Clin Oncol (R Coll Radiol). 2012;24(10):e173–9.
Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63(7):917–28.
Warren TA, Panizza B, Porceddu SV, Gandhi M, Patel P, Wood M, et al. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head Neck. 2014 Dec 24. doi: 10.1002/hed.23982. [Epub ahead of print] PubMed PMID: 25546817.
Dunn M, Morgan MB, Beer TW. Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg. 2009;35(2):214–21.
Xie P, Yue JB, Fu Z, Feng R, Yu JM. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. Ann Oncol. 2010;21(5):1078–82. doi:10.1093/annonc/mdp430. Epub 2009 Nov 13.
Jung EJ, Han HS, Koh YC, Cho J, Ryu CG, Paik JH, et al. Metachronous schwannoma in the colon with vestibular schwannoma. Ann Surg Treat Res. 2014;87(3):161–5.
Roselli F, Pisciotta NM, Aniello MS, Niccoli-Asabella A, Defazio G, Livrea P, et al. Brain F-18 Fluorocholine PET/CT for the assessment of optic pathway glioma in neurofibromatosis-1. Clin Nucl Med. 2010;35(10):838–9.
Muzaffar R, Shousha MA, Sarajlic L, Osman MM. Ophthalmologic abnormalities on FDG-PET/CT: a pictorial essay. Cancer Imaging. 2013;13:100–12.
Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35(2):500–16.
Moharir M, London K, Howman-Giles R, North K. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging. 2010;37(7):1309–17.
Miyamoto J, Tatsuzawa K, Owada K, Kawabe T, Sasajima H, Mineura K. Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors. Neurol Med Chir (Tokyo). 2008;48(11):495–9. discussion 499.
Mölenkamp G, Riemann B, Kuwert T, Sträter R, Kurlemann G, Schober O, et al. Monitoring tumor activity in low grade glioma of childhood. Klin Padiatr. 1998;210(4):239–42.
Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun. 2012;33(9):907–16.
Ginsberg LE. Imaging of perineural tumor spread in head and neck cancer. Semin Ultrasound CT MR. 1999;20(3):175–86.
Nemec SF, Herneth AM, Czerny C. Perineural tumor spread in malignant head and neck tumors. Top Magn Reson Imaging. 2007;18(6):467–71.
Lopci E, Monti L, Balzarini L, Chiti A. Cardiac and acoustic metastases in relapsing melanoma. Clin Nucl Med. 2013;38(2):e85–8.
Macdonald AJ, Salzman KL, Harnsberger HR, Gilbert E, Shelton C. Primary jugular foramen meningioma: imaging appearance and differentiating features. AJR Am J Roentgenol. 2004;182(2):373–7.
Thompson EO, Smoker WR. Hypoglossal nerve palsy: a segmental approach. Radiographics. 1994;14(5):939–58.
Santarius T, Dakoji S, Afshari FT, Raymond FL, Firth HV, Fernandes HM, et al. Isolated hypoglossal schwannoma in a 9-year old child. J Neurosurg Pediatr. 2012;10(2):130–3.
Acknowledgment
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
Dr. Osman: Speaker, Koninklijke Philips NV. All other authors have no financial disclosures.
Authors’ contributions
All Authors: 1) Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; 3) have given final approval of the version to be published; and 4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors read and approved the final manuscript.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Raslan, O.A., Muzaffar, R., Shetty, V. et al. Image findings of cranial nerve pathology on [18F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT): a pictorial essay. cancer imaging 15, 20 (2015). https://doi.org/10.1186/s40644-015-0054-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40644-015-0054-0